Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CRVS

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CRVS

  • Market Cap$109.900m
  • SymbolNASDAQ:CRVS
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS2210151005

Company Profile

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing small-molecule and antibody agents that target the immune system to treat patients with cancer. The firm's pipeline includes CPI-006, CPI-818, CPI-935, and others.Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is engaged in development and commercialization of novel immuno-oncology therapies that are designed to harness the immune system to attack cancer cells.

Latest CRVS news

Currently there for this company. Visit our news hub for other news .